ATRX and neuroendocrine neoplasm: Somatic alpha thalassemia/mental retardation syndrome X-linked (ATRX) pathogenic variants have been shown to predict malignant phenotypes in neuroendocrine tumors, such as pancreatic neuroendocrine tumors and pheochromocytoma/paraganglioma (1).